# A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer

> **NCT04147806** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Albert Einstein College of Medicine** · enrollment: 31 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** IGRT 45 Gy in 5 fractions of 9 Gy
- **RADIATION:** IGRT 24 Gy single dose
- **DRUG:** Dexamethasone
- **DRUG:** Tamsulosin

## Key facts

- **NCT ID:** NCT04147806
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-08-01
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04147806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04147806, "A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04147806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*